Anteilseigner
Broadwood Capital, Inc. (22,10 %) The Vanguard Group, Inc. (4,28 %) BlackRock Fund Advisors (4,17 %) Greenway Partners LP (3,63 %) Logos Global Management LP (3,32 %) Defender Capital LLC (2,63 %) Geode Capital Management LLC (1,73 %) Raffles Capital Management LLC (1,70 %) SSgA Funds Management, Inc. (1,15 %) Prescott General Partners LLC (0,98 %) MAI Capital Management LLC (0,79 %) DAFNA Capital Management LLC (0,72 %) Bank of America, NA (Private Banking) (0,69 %) Northern Trust Investments, Inc.(Investment Management) (0,65 %) Bridgeway Capital Management LLC (0,36 %) JPMorgan Asset Management (UK) Ltd. (0,33 %) KSM Mutual Funds Ltd. (0,32 %) British & American Investment Trust Plc (Invt Mgmt) (0,30 %) Renaissance Technologies LLC (0,28 %) Wellington Management Co. LLP (0,25 %)
Kontakt
Lineage Cell Therapeutics Inc.
Salk Avenue, Suite 200 2173
92008 Carlsbad